Webinars

Our informative webinars are in partnership with the Journal of Parkinson’s Disease and Parkinson’s Movement.

These quarterly webinars are each chaired by Professor Patrick Brundin (Van Andel Research Institute) who is joined by a different panel of experts discussing important topics and related research within the Parkinson's community.

Re-watch the webinars here...

Webinar - Neurotrophic Factors and Parkinson's

Re-watch - This expert webinar panel includes: Dr. Howard Federoff - Professor of Neurology and Neuroscience, University of California; Prof. Mart Saarma - University of Helsinki and Lyndsey Isaacs - Trustee, The Cure Parkinson's Trust. Read more

Webinar - Inflammation in Parkinson's

Once again chaired by Van Andel Institute’s Professor Patrik Brundin - this panel discusses the topic of 'Inflammation in Parkinson's'. Read more

Webinar - Exercise and Parkinson's

Re-watch our webinar discussing recent publications around the theme of exercise in Parkinson’s. Read more

Webinar - Dyskinesia in Parkinson's

Chair Professor Patrik Brundin is joined by Professor Ray Chaudhuri, Professor Angela Cenci Nilsson and patient advocate Martin Taylor as they discuss recent publications around the theme of 'Dyskinesias in Parkinson’s.' Read more

Webinar - How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions and Histology.

The panel discuss the paper 'How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology' by Professor Per Borghammer Read more

Webinar - Does Exenatide reduce Non-motor Symptoms in Parkinson’s?

Professor Brundin is joined by Professor Tom Foltynie who led the exenatide trial... Read more

Webinar - Sleep and Parkinson’s Disease

Professor Patrik Brundin is joined by a panel of experts discussing ‘Sleep and Parkinson’s Disease’. Read more

Webinar - Targeting the Genetics of Parkinson's

Professor Patrik Brundin leads a panel discussing the genetics of Parkinson's... Read more

Webinar - Stem Cell (Cell Replacement) Therapy

This webinar focuses on developments in the field of stem cell therapy for Parkinson's... Read more

Latest

Further Evidence of Neuroprotection of Simvastatin in Parkinson's

Researchers in Israel have recently published an interesting new study which provides a novel insight and further independent support for simvastatin which CPT is clinically testing in people with Parkinson's.

My Prudential RideLondon Challenge

Over the weekend of the 15 -16 August, please join us for the nation-wide ‘virtual’ My Prudential RideLondon challenge and support our pioneering Parkinson's research. Get on your bike, or any form of self-propelled wheels, and ride around your local area to take part. Find out more...

‘Virtual’ Edinburgh Marathon Festival 2020 Challenge

Join this year’s ‘virtual’ Edinburgh Marathon Festival Challenge around your local area in support of The Cure Parkinson’s Trust. Participants can choose how and when to take part in this virtual running event with different distances that can be completed anytime between now and the 31 December.

'Cabbages and Kings Magazine' in support of CPT

Long term supporters from the Leicestershire, Northamptonshire and Rutland Committee led by Meriel Buxton have produced and printed a wonderful magazine 'Cabbages and Kings' to help raise funds for CPT’s research.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

Science news

Read the latest Parkinson's science and research news here.

Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

Apply for Funding

The NAC Trial - the facts

Our story

Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.